A Modified Laparoscopic Sleeve Gastrectomy For The Treatment Of Diabetes Mellitus Type 2 And Metabolic Syndrome In Obesity | 6433
Journal of Obesity & Weight Loss Therapy
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Ghrelin is a gastrointestinal peptide hormone (a 28 ?amino acid peptide) produced primarily by X/A cells in
the oxyntic glands of the stomach fundus and cells lining the duodenum cavern. It suppresses insulin secretion and action and
commands a significant role in regulating food intake. The aim of the present study was to show that modified laparoscopic sleeve
gastrectomy(MLSG), in which a significant part of the gastric fundus and body of the stomach is removed up to 1 inch from the
pylorus vein, may contribute to decreasing circulating ghrelin levels.
A study population consisting of 150 individuals was monitored after undergoing a MLSG, with individuals chosen
based on a documented history of diabetes mellitus type 2 and metabolic syndrome, clinical results determining a body mass
index (BMI) of 35 to 60 kg/m2, peptide C level greater than 1, negative anti-GAD, negative anti-insulin, and confirmed stability
of drug/insulin treatment and glycosylated hemoglobin greater than 6.5% for at least 24 and 3 months, respectively, before
Twenty-four months after surgery, 150 patients (86.6%) presented with normal glycemic levels between 77 and 99 mg/
dL. All patients improved average serum insulin levels by 9 mU/L and average glycosylated hemoglobin levels by 5.1% (normal
range, 4%? 6%). All patients tested negative for Helicobacter pylori and stopped using insulin, with 3 patients prescribed twice-
daily use of an oral hypoglycemiant. In 14% of cases, patients experienced partial hair loss with low serum zinc levels and were
prescribed oral zinc reposition and topical hair stimulants. The average weight loss recorded was 44.6% for patients with a BMI
less than 45 kg/m2 and 58% for patients with a BMI greater than 50 kg/m2.
The MLSG is a safe procedure with a low morbidity rate (2.7%) (4 cases of fistula and 2 of bleeding) and no surgical
mortality. This surgery can promote control of diabetes mellitus type 2 and aid the treatment of exogenous overweight and
morbidly obese individuals. The results of this study show that only through resection of the ghrelin-producing gastric area can
most obesity cases and diabetes type II conditions be reverted to nonobese and controlled diabetes
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals